TRT Lab Schedule: Starter to Stable to Maintenance

Starting TRT is just the beginning. Knowing what to test and when separates smooth optimization from months of guessing. This guide gives you the exact lab schedule—from pre-TRT baseline through your first year and beyond.

Phase 1: Pre-TRT Baseline (Before Starting)

Why it matters: You need to know where you started. Many men discover issues only after seeing baseline labs—thyroid problems, anemia, sleep apnea markers—that affect how they feel independent of testosterone.

Full baseline panel:

Hormones:

• Total testosterone
• Free testosterone (or calculated free)
• SHBG
• Estradiol (sensitive/ultrasensitive assay)
• DHT (optional but useful)
• LH and FSH (to confirm hypogonadism)
• Prolactin
• Cortisol (morning)

Metabolic and general health:

• CBC (complete blood count)
• CMP (comprehensive metabolic panel)
• Lipid panel
• Fasting insulin and glucose (or HOMA-IR)
• Thyroid panel (TSH, free T3, free T4)
• PSA (prostate-specific antigen)
• Ferritin/iron panel

Additional considerations:

• Vitamin D
• DHEA-S
• Pregnenolone
• Sleep study if symptoms suggest apnea

When to test: Within 2–4 weeks before starting TRT. Don't use labs from 6 months ago—hormones fluctuate.

Phase 2: Initial Titration (Weeks 6–8)

Why it matters: This is your first checkpoint to see how your initial protocol is working. Most providers start with a standard dose, but individual needs vary significantly.

What to test:

• Total testosterone
• Free testosterone
• Estradiol (sensitive)
• CBC (check hematocrit/hemoglobin)
• PSA (if over 40 or family history)

What you're looking for:

Testosterone: Mid-range to upper-range total T (usually 600–900 ng/dL depending on lab). Free T in upper-normal range.

Estradiol: 20–40 pg/mL is typical target, but symptoms matter more than numbers.

Hematocrit: If it's risen significantly (above 50–52%), you'll need management strategies.

Adjustments at this stage:

• Dose changes (most common: slight increases or decreases)
• Injection frequency changes (if levels are erratic)
• Estradiol management if symptomatic

Phase 3: Optimization (Months 3–6)

Why it matters: By month 3, you've likely found a workable dose. Now you're refining—fine-tuning frequency, evaluating symptom resolution, and catching any developing issues.

Month 3 labs:

• Total testosterone
• Free testosterone
• Estradiol
• CBC (hematocrit check)
• PSA (if indicated)
• Lipids (TRT can affect these)
• Fasting insulin/glucose

Month 6 labs:

• Full hormone panel (T, free T, SHBG, estradiol)
• CBC
• CMP (liver/kidney function)
• Lipid panel
• PSA
• Thyroid panel (recheck if borderline before)

What you're evaluating:

• Symptom resolution (libido, energy, cognition, body composition)
• Side effect management (hematocrit, estradiol, acne, hair loss)
• Metabolic markers (insulin sensitivity often improves on TRT)

Optimization focus:

• If symptoms aren't resolved, adjust dose
• If side effects are problematic, address root causes
• If hematocrit is climbing, implement management strategies

Phase 4: Stable Protocol (Months 6–12)

Why it matters: Once stable, you're monitoring rather than adjusting. Catching trends early prevents problems.

Month 9 (optional but recommended):

• Total testosterone
• Free testosterone
• Estradiol
• CBC

Month 12 (annual full panel):

• Complete hormone panel (total T, free T, SHBG, estradiol, DHT)
• CBC with differential
• CMP
• Lipid panel
• Fasting insulin and glucose
• PSA
• Thyroid panel
• Ferritin/iron

Annual additions to consider:

• Bone density scan (if low testosterone was prolonged or if on TRT long-term)
• Sleep study recheck (if you had apnea or symptoms suggest recurrence)
• Cardiovascular risk assessment (if family history or other risk factors)

Phase 5: Long-Term Maintenance (Year 2+)

Why it matters: Long-term TRT is safe for most men, but monitoring catches the rare issues and ensures continued optimization.

Every 6 months:

• Total testosterone
• Free testosterone
• Estradiol
• CBC (hematocrit is the critical marker here)

Annually:

• Full panel as outlined in month 12
• PSA (continues annually if over 50, or earlier if risk factors)
• Consider DEXA scan every 2–3 years for bone density

Ongoing monitoring:

• Symptoms (libido, energy, mood, cognition, body composition)
• Side effects (acne, hair loss, water retention, gynecomastia)
• Injection site reactions
• Fertility status (if relevant)

Special Circumstances: When to Test Sooner

Test immediately if you develop:

• Chest pain or shortness of breath (check hematocrit—rare but possible polycythemia)
• Significant mood changes or depression
• Urinary symptoms (check PSA if over 40)
• Severe acne or rapid hair loss
• Testicular pain or changes
• Significant fluid retention

Test sooner than scheduled if:

• You've changed your protocol (new dose, new frequency, new injection site)
• You've started new medications that might interact
• You've had significant lifestyle changes (weight loss >10%, new exercise program, major stress)
• Symptoms return or change significantly

Lab Timing Best Practices

When to draw blood:

For trough levels (most common): Draw blood immediately before your next injection. This shows your lowest point and is what most clinicians use for dosing decisions.

For peak levels: Draw 24–48 hours after injection (varies by ester—cypionate/enanthate peak around 24–48 hours). Rarely necessary unless troubleshooting specific issues.

For mid-cycle levels: Some clinicians prefer mid-point between injections for average exposure.

Consistency matters: Always test at the same point in your injection cycle. Comparing a trough from one test to a peak from another will give meaningless data.

Fasting:

• Lipids and fasting insulin/glucose: 12-hour fast
• Hormones: fasting not required but be consistent (either always fasted or always non-fasted)
• CBC/CMP: fasting not required

Time of day:

• Cortisol: Morning (8–10 AM) only
• Testosterone: Less time-sensitive on TRT than natural production, but morning is traditional

Key Takeaways

1. Baseline labs are non-negotiable. You need to know where you started.
2. Weeks 6–8: First adjustment checkpoint. Most protocols need refinement.
3. Months 3–6: Optimization phase. Fine-tuning frequency, evaluating symptoms.
4. Month 12: First annual full panel. Establishes your stable pattern.
5. Long-term: Every 6 months for CBC/hormones, annually for full metabolic workup.
6. Consistency in timing: Always test at the same point in your injection cycle.
7. Track symptoms alongside labs: Numbers guide, but how you feel drives decisions.

References

1. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. Link
2. Snyder PJ, Bhasin S, Cunningham GR, et al. Effects of Testosterone Treatment in Older Men. N Engl J Med. 2016;374(7):611-624. Link
3. Snyder PJ, Bhasin S, Cunningham GR, et al. The Testosterone Trials: Seven coordinated trials of testosterone treatment in elderly men. Clin Trials. 2014;11(3):362-375. Link
4. Cervi A, Balitsky AK. Testosterone therapy and secondary erythrocytosis. Can Urol Assoc J. 2022;16(5):E245-E248. Link
5. Lincoff AM, Bhasin S, Flevaris P, et al. Cardiovascular Safety of Testosterone-Replacement Therapy. N Engl J Med. 2023;389(2):107-117. Link
6. Mulhall JP, Trost LW, Brannigan RE, et al. Evaluation and Management of Testosterone Deficiency: AUA Guideline. J Urol. 2018;200(2):423-432. Link